Trademark Attorney / Law Firm
Timothy Hardesty – Trademark Portfolio
Timothy Hardesty has filed 8 trademarks with the United States Patent and Trademark Office (USPTO). Filing records are from 2018. Of these filings, 2 are currently registered. The portfolio covers 8 Nice Classification classes, with the highest concentration in Class 5 (Pharmaceuticals, 2 filings) and Class 44 (Medical Services, 2 filings).
Showing of trademarks Trademarks
Practice Areas by Trademark Class
Timothy Hardesty's trademark practice covers 8 Nice Classification classes, representing the range of industries and goods/services handled in their USPTO filings.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Scientific and technological services; industrial analysis and research services
Education; providing of training; entertainment; sporting and cultural activities
Precious metals and their alloys; jewellery, precious stones; horological instruments
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademark applications has Timothy Hardesty filed?
Timothy Hardesty has filed 8 trademark applications with the United States Patent and Trademark Office (USPTO). Of these, 2 registered, 3 abandoned, 3 cancelled.
What trademark classes does Timothy Hardesty specialize in?
Timothy Hardesty has filed trademarks across 8 Nice Classification classes. The most common practice areas include Class 5 (Pharmaceuticals), Class 44 (Medical Services), Class 42 (Computer & Scientific), Class 41 (Education & Entertainment), Class 14 (Jewelry). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What is Timothy Hardesty's trademark registration success rate?
Timothy Hardesty has a 25% trademark registration rate, with 2 out of 8 resolved applications resulting in successful registration. Currently, 0 applications are pending review.